1. Home
  2. NERV vs CVR Comparison

NERV vs CVR Comparison

Compare NERV & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NERV
  • CVR
  • Stock Information
  • Founded
  • NERV 2007
  • CVR 1920
  • Country
  • NERV United States
  • CVR United States
  • Employees
  • NERV N/A
  • CVR N/A
  • Industry
  • NERV Biotechnology: Pharmaceutical Preparations
  • CVR Industrial Machinery/Components
  • Sector
  • NERV Health Care
  • CVR Industrials
  • Exchange
  • NERV Nasdaq
  • CVR Nasdaq
  • Market Cap
  • NERV 12.4M
  • CVR 14.9M
  • IPO Year
  • NERV 2014
  • CVR N/A
  • Fundamental
  • Price
  • NERV $1.52
  • CVR $11.32
  • Analyst Decision
  • NERV Hold
  • CVR
  • Analyst Count
  • NERV 1
  • CVR 0
  • Target Price
  • NERV $5.00
  • CVR N/A
  • AVG Volume (30 Days)
  • NERV 5.9K
  • CVR 6.5K
  • Earning Date
  • NERV 05-13-2025
  • CVR 05-09-2025
  • Dividend Yield
  • NERV N/A
  • CVR 1.09%
  • EPS Growth
  • NERV N/A
  • CVR N/A
  • EPS
  • NERV 0.82
  • CVR N/A
  • Revenue
  • NERV N/A
  • CVR $26,379,081.00
  • Revenue This Year
  • NERV N/A
  • CVR N/A
  • Revenue Next Year
  • NERV N/A
  • CVR N/A
  • P/E Ratio
  • NERV $1.95
  • CVR N/A
  • Revenue Growth
  • NERV N/A
  • CVR N/A
  • 52 Week Low
  • NERV $1.15
  • CVR $8.25
  • 52 Week High
  • NERV $3.69
  • CVR $22.27
  • Technical
  • Relative Strength Index (RSI)
  • NERV 40.93
  • CVR 48.95
  • Support Level
  • NERV $1.58
  • CVR $10.48
  • Resistance Level
  • NERV $1.74
  • CVR $11.65
  • Average True Range (ATR)
  • NERV 0.06
  • CVR 1.35
  • MACD
  • NERV -0.01
  • CVR 0.05
  • Stochastic Oscillator
  • NERV 0.00
  • CVR 50.08

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

About CVR Chicago Rivet & Machine Co.

Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment. Geographically, the majority is from the United States.

Share on Social Networks: